Results 171 to 180 of about 25,773 (228)

Revisiting the Gray Zone in HBeAg-Negative Chronic Hepatitis B: Insights From a Multicenter Liver Biopsy Cohort. [PDF]

open access: yesTurk J Gastroenterol
Gül Ö   +6 more
europepmc   +1 more source

HBsAg glycan isomer: a potential circulating biomarker for monitoring cccDNA and predicting virologic response in chronic hepatitis B. [PDF]

open access: yesFront Cell Infect Microbiol
Li J   +10 more
europepmc   +1 more source

Dual HBV cccDNA-linked HiBiT reporter hepatocyte models for screening of candidate cccDNA modulators. [PDF]

open access: yesVirulence
Cao J   +13 more
europepmc   +1 more source

Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients With HBeAg-Negative Chronic Hepatitis B

open access: yesNew England Journal of Medicine, 2004
BACKGROUND: Available treatments for hepatitis B e antigen (HBeAg)-negative chronic hepatitis B are associated with poor sustained responses. As a result, nucleoside and nucleotide analogues are typically continued indefinitely, a strategy ...
Patrick Marcellin   +2 more
exaly   +1 more source

Home - About - Disclaimer - Privacy